| Serial Number | 88662693 |
| Word Mark | DIGENESIS |
| Filing Date | Monday, October 21, 2019 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Tuesday, June 21, 2022 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, August 18, 2020 |
| Pseudo Mark | DI GENESIS |
| Goods and Services | business consulting and management in the fields of medical research, pharmaceutical development and clinical trials for business purposes; business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes; business consulting and management in the field of pharmaceutical development, namely, management and compilation of computerized databases in the field of pharmaceutical development for business purposes; business consulting and management in the field of pharmaceutical development, namely, management and compilation of computerized databases in the field of medical research for business purposes; all of the foregoing excluding the field of digenesis |
| Goods and Services | providing medical and scientific research information in the fields of medical research, pharmaceutical development and clinical trials; consulting services for others in the field of design and planning of clinical trials; consulting services for others in the fields of medical research and pharmaceutical development; consulting services for others in the fields of medical research and pharmaceutical development, namely, providing digital models of patients for use as simulated control subjects; consulting services for others in the field of design and planning of clinical trials, namely, providing digital models of patients for use as simulated control subjects for clinical trials; providing data analytics and artificial intelligence in the nature of non-downloadable software, for use in the design and planning of clinical trials; providing data analytics and artificial intelligence in the nature of non-downloadable software, for use in medical research and pharmaceutical development; providing data analytics and artificial intelligence in the nature of non-downloadable software, for use in the life sciences field for the purpose of research, development, and commercialization; providing a website featuring educational information in the fields of medical research, pharmaceutical development, clinical trials and artificial intelligence; all of the foregoing excluding the field of digenesis |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, October 25, 2019 |
| Primary Code | 035 |
| First Use Anywhere Date | Monday, March 22, 2021 |
| First Use In Commerce Date | Monday, March 22, 2021 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, October 25, 2019 |
| Primary Code | 042 |
| First Use Anywhere Date | Monday, March 22, 2021 |
| First Use In Commerce Date | Monday, March 22, 2021 |
| Party Name | UNLEARN.AI, INC. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | San Francisco, CA 94105 |
| Party Name | UNLEARN.AI, INC. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | San Francisco, CA 94105 |
| Event Date | Event Description |
| Tuesday, June 21, 2022 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Tuesday, June 21, 2022 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Monday, December 6, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, December 6, 2021 | NON-FINAL ACTION E-MAILED |
| Monday, December 6, 2021 | SU - NON-FINAL ACTION - WRITTEN |
| Tuesday, November 9, 2021 | STATEMENT OF USE PROCESSING COMPLETE |
| Wednesday, October 20, 2021 | USE AMENDMENT FILED |
| Friday, November 5, 2021 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Wednesday, October 20, 2021 | TEAS STATEMENT OF USE RECEIVED |
| Tuesday, October 12, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, October 8, 2021 | SOU EXTENSION 2 GRANTED |
| Friday, October 8, 2021 | SOU EXTENSION 2 FILED |
| Friday, October 8, 2021 | TEAS EXTENSION RECEIVED |
| Wednesday, April 14, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, April 12, 2021 | SOU EXTENSION 1 GRANTED |
| Monday, April 12, 2021 | SOU EXTENSION 1 FILED |
| Monday, April 12, 2021 | TEAS EXTENSION RECEIVED |
| Tuesday, October 13, 2020 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, August 18, 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, August 18, 2020 | PUBLISHED FOR OPPOSITION |
| Wednesday, July 29, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Monday, July 13, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, May 28, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, May 27, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, May 27, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, April 16, 2020 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Thursday, April 16, 2020 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Thursday, April 16, 2020 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Monday, February 3, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, February 3, 2020 | NON-FINAL ACTION E-MAILED |
| Monday, February 3, 2020 | NON-FINAL ACTION WRITTEN |
| Monday, January 27, 2020 | ASSIGNED TO EXAMINER |
| Friday, October 25, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Thursday, October 24, 2019 | NEW APPLICATION ENTERED IN TRAM |